TickerFacts.

Neogen Corp (NEOG): Revenue

Annual figures by period end, from SEC filings.

$870.40M
Year ended 2026-05-31
+1.9%
3-year compound annual growth
+13.2%
5-year compound annual growth
+10.5%
10-year compound annual growth
$924.20M2010-05-31: $140.51M2011-05-31: $172.68M2012-05-31: $184.05M2013-05-31: $207.53M2014-05-31: $247.41M2015-05-31: $283.07M2016-05-31: $321.27M2017-05-31: $358.28M2018-05-31: $397.93M2019-05-31: $414.19M2020-05-31: $418.17M2021-05-31: $468.46M2022-05-31: $527.16M2023-05-31: $822.45M2024-05-31: $924.20M2025-05-31: $894.70M2026-05-31: $870.40M$870.40M
2010-05-31 Revenue (USD) 2026-05-31
Period endedRevenueChange YoYSource filing
2026-05-31$870.40M-2.7%2026-07-30, From 2025-06-01
2025-05-31$894.70M-3.2%2026-07-30, From 2024-06-01
2024-05-31$924.20M+12.4%2026-07-30, From 2023-06-01
2023-05-31$822.45M+56.0%2025-07-30, From 2022-06-01
2022-05-31$527.16M+12.5%2024-07-30, From 2021-06-01
2021-05-31$468.46M+12.0%2023-08-15, From 2020-06-01
2020-05-31$418.17M+1.0%2022-07-27, From 2019-06-01
2019-05-31$414.19M+4.1%2021-07-30, From 2018-06-01
2018-05-31$397.93M+11.1%2020-07-30, From 2017-06-01
2017-05-31$358.28M+11.5%2019-07-30, From 2016-06-01
2016-05-31$321.27M+13.5%2018-07-27, From 2015-06-01
2015-05-31$283.07M+14.4%2017-07-28, From 2014-06-01
2014-05-31$247.41M+19.2%2016-07-29, From 2013-06-01
2013-05-31$207.53M+12.8%2015-07-30, From 2012-06-01
2012-05-31$184.05M+6.6%2014-07-30, From 2011-06-01
2011-05-31$172.68M+22.9%2013-07-30, From 2010-06-01
2010-05-31$140.51Mn/a2012-07-30, From 2009-06-01

Revenue at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Neogen Corp (NEOG)2026-05-31$870.40M-2.7%
Myriad Genetics Inc (MYGN)2025-12-31$824.50M-1.6%
Lantheus Holdings, Inc. (LNTH)2025-12-31$1.54B+0.5%
QuidelOrtho Corp (QDEL)2025-12-28$2.73B-1.9%
Idexx Laboratories Inc (IDXX)2025-12-31$4.30B+10.4%
Intellia Therapeutics, Inc. (NTLA)2025-12-31$67.67M+16.9%
Alpha Teknova, Inc. (TKNO)2025-12-31$40.52M+7.4%
Immucell Corp (ICCC)2025-12-31$27.64M+4.3%
Aspira Women's Health Inc. (AWHL)2025-12-31$9.22M+0.4%

Compare NEOG, MYGN, LNTH, QDEL side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗